Login / Signup

Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients.

Yue HaoGen LinJing XiangWen-Xian WangChun-Wei XuQian WangJing CaiYong-Chang ZhangZhengbo Song
Published in: Cancer medicine (2022)
Immunotherapy elicited a response in thymoma patients; however, more attention should be paid to the immune-related adverse events.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • drug induced